Mallika Alvala

2.1k total citations
68 papers, 1.6k citations indexed

About

Mallika Alvala is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Mallika Alvala has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 30 papers in Organic Chemistry and 15 papers in Immunology. Recurrent topics in Mallika Alvala's work include Galectins and Cancer Biology (13 papers), Synthesis and biological activity (9 papers) and Cancer therapeutics and mechanisms (8 papers). Mallika Alvala is often cited by papers focused on Galectins and Cancer Biology (13 papers), Synthesis and biological activity (9 papers) and Cancer therapeutics and mechanisms (8 papers). Mallika Alvala collaborates with scholars based in India, Italy and France. Mallika Alvala's co-authors include Ravi Alvala, Sridhar Goud Nerella, Dharmarajan Sriram, Perumal Yogeeswari, Aaftaab Sethi, Mohammed Arifuddin, Claudiu T. Supuran, Andrea Angeli, A. Prasanth Saraswati and Arunasree M. Kalle and has published in prestigious journals such as PLoS ONE, Chemical Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Mallika Alvala

68 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mallika Alvala India 25 766 689 189 146 136 68 1.6k
Chih-Hua Tseng Taiwan 27 826 1.1× 891 1.3× 78 0.4× 195 1.3× 140 1.0× 86 1.9k
Arunasree M. Kalle India 22 662 0.9× 735 1.1× 43 0.2× 174 1.2× 230 1.7× 43 1.7k
Anil Nilkanth Gaikwad India 27 675 0.9× 656 1.0× 108 0.6× 63 0.4× 92 0.7× 65 1.7k
K. Venkateswara Swamy India 21 533 0.7× 293 0.4× 58 0.3× 152 1.0× 107 0.8× 57 1.3k
S. Nanjunda Swamy India 23 809 1.1× 883 1.3× 87 0.5× 256 1.8× 163 1.2× 86 2.0k
Gopalakrishnan Bulusu India 25 803 1.0× 339 0.5× 79 0.4× 54 0.4× 134 1.0× 62 1.4k
Erika Roat Italy 19 754 1.0× 149 0.2× 193 1.0× 133 0.9× 62 0.5× 26 1.6k
Maria Giovanna Chini Italy 26 1.0k 1.4× 526 0.8× 83 0.4× 411 2.8× 394 2.9× 86 2.2k
Nan Ma China 20 825 1.1× 361 0.5× 209 1.1× 287 2.0× 129 0.9× 90 1.7k
Tulika Bhardwaj India 20 651 0.8× 326 0.5× 91 0.5× 145 1.0× 85 0.6× 74 1.3k

Countries citing papers authored by Mallika Alvala

Since Specialization
Citations

This map shows the geographic impact of Mallika Alvala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallika Alvala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallika Alvala more than expected).

Fields of papers citing papers by Mallika Alvala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallika Alvala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallika Alvala. The network helps show where Mallika Alvala may publish in the future.

Co-authorship network of co-authors of Mallika Alvala

This figure shows the co-authorship network connecting the top 25 collaborators of Mallika Alvala. A scholar is included among the top collaborators of Mallika Alvala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallika Alvala. Mallika Alvala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nerella, Sridhar Goud, Ravi Alvala, Arunasree M. Kalle, & Mallika Alvala. (2024). Design and synthesis of novel coumarin–benzimidazole hybrids as human galectin-1 inhibitors. Future Medicinal Chemistry. 16(9). 843–857. 5 indexed citations
3.
Alvala, Mallika, et al.. (2024). Structural and catalytic properties of histidyl-tRNA synthetase: A potential drug target against leishmaniasis. International Journal of Biological Macromolecules. 282(Pt 6). 137357–137357. 1 indexed citations
4.
Alvala, Mallika & Aaftaab Sethi. (2022). β-CD/Lewis Acid Dual Catalytic System for Efficient Synthesis ofPyranopyrazoles in Aqueous Environment. Letters in Organic Chemistry. 20(7). 585–595. 1 indexed citations
5.
Nerella, Sridhar Goud, Mohammed Arifuddin, Mallika Alvala, et al.. (2021). Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors. Bioorganic & Medicinal Chemistry Letters. 39. 127877–127877. 16 indexed citations
6.
7.
Arifuddin, Mohammed, et al.. (2019). Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors. Bioorganic Chemistry. 87. 765–772. 47 indexed citations
8.
Nerella, Sridhar Goud, et al.. (2019). Synthesis, molecular docking simulation, and biological evaluation studies of novel amide and ether conjugates of 2,3‐diaryl‐1,3‐thiazolidin‐4‐ones. Journal of Heterocyclic Chemistry. 57(2). 774–790. 9 indexed citations
9.
Bonam, Srinivasa Reddy, et al.. (2019). Novel trisaccharide based phospholipids as immunomodulators. International Immunopharmacology. 74. 105684–105684. 12 indexed citations
10.
Digwal, Chander Singh, Andrea Angeli, Mallika Alvala, et al.. (2019). Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors. Bioorganic & Medicinal Chemistry. 27(21). 115090–115090. 15 indexed citations
11.
Narva, Suresh, et al.. (2018). Design, Synthesis, and Biological Evaluation of 2‐(4‐Aminophenyl)benzothiazole Analogues as Antiproliferative Agents. Journal of Heterocyclic Chemistry. 56(2). 520–532. 16 indexed citations
12.
Nerella, Sridhar Goud, Mohammed Arifuddin, Mukesh Doble, et al.. (2018). An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors. Chemical Biology & Drug Design. 92(6). 1933–1939. 12 indexed citations
13.
Alvala, Mallika, K. Shiva Kumar, Raj Patel, et al.. (2017). Mycobacterium tuberculosis chorismate mutase: A potential target for TB. Bioorganic & Medicinal Chemistry. 25(6). 1725–1736. 41 indexed citations
14.
Bandaru, Srinivas, et al.. (2015). Identification of High Affinity Bioactive Salbutamol Conformer Directed Against Mutated (Thr164Ile) Beta 2 Adrenergic Receptor. Current Topics in Medicinal Chemistry. 15(1). 50–56. 22 indexed citations
15.
Alvala, Mallika, et al.. (2014). Structure-based drug design of small molecule SIRT1 modulators to treat cancer and metabolic disorders. Journal of Molecular Graphics and Modelling. 52. 46–56. 23 indexed citations
16.
Devi, Parthiban Brindha, Ganesh Samala, Jonnalagadda Padma Sridevi, et al.. (2014). Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors. ChemMedChem. 9(11). 2538–2547. 26 indexed citations
17.
Dalimba, Udayakumar, et al.. (2013). Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition. European Journal of Medicinal Chemistry. 69. 125–138. 30 indexed citations
18.
Alvala, Ravi, et al.. (2013). Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark. Journal of Ethnopharmacology. 148(2). 441–448. 19 indexed citations
19.
Alvala, Mallika, Shubhmita Bhatnagar, Ravi Alvala, et al.. (2012). Novel acridinedione derivatives: Design, synthesis, SIRT1 enzyme and tumor cell growth inhibition studies. Bioorganic & Medicinal Chemistry Letters. 22(9). 3256–3260. 35 indexed citations
20.
Alvala, Ravi, et al.. (2011). Antiproliferative activity and standardization of Tecomella undulata bark extract on K562 cells. Journal of Ethnopharmacology. 137(3). 1353–1359. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chih-Hua Tseng Breakdown of academic impact, for papers by Arunasree M. Kalle Breakdown of academic impact, for papers by Anil Nilkanth Gaikwad Breakdown of academic impact, for papers by K. Venkateswara Swamy Breakdown of academic impact, for papers by S. Nanjunda Swamy Breakdown of academic impact, for papers by Gopalakrishnan Bulusu Breakdown of academic impact, for papers by Erika Roat Breakdown of academic impact, for papers by Maria Giovanna Chini Breakdown of academic impact, for papers by Nan Ma Breakdown of academic impact, for papers by Tulika Bhardwaj
Rankless by CCL
2026